Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novanta (NOVT) Gains from Sales and Divestitures: 2012-2025

Historic Gains from Sales and Divestitures for Novanta (NOVT) over the last 14 years, with Sep 2025 value amounting to $91,000.

  • Novanta's Gains from Sales and Divestitures fell 10.78% to $91,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $91,000, marking a year-over-year decrease of 10.78%. This contributed to the annual value of $107,000 for FY2024, which is 1.83% down from last year.
  • According to the latest figures from Q3 2025, Novanta's Gains from Sales and Divestitures is $91,000, which was up 9.64% from $83,000 recorded in Q2 2025.
  • Over the past 5 years, Novanta's Gains from Sales and Divestitures peaked at $487,000 during Q4 2021, and registered a low of $72,000 during Q1 2025.
  • For the 3-year period, Novanta's Gains from Sales and Divestitures averaged around $94,364, with its median value being $97,000 (2024).
  • As far as peak fluctuations go, Novanta's Gains from Sales and Divestitures spiked by 305.83% in 2021, and later plummeted by 72.16% in 2022.
  • Over the past 5 years, Novanta's Gains from Sales and Divestitures (Quarterly) stood at $487,000 in 2021, then plummeted by 67.97% to $156,000 in 2022, then tumbled by 30.13% to $109,000 in 2023, then fell by 1.83% to $107,000 in 2024, then declined by 10.78% to $91,000 in 2025.
  • Its last three reported values are $91,000 in Q3 2025, $83,000 for Q2 2025, and $72,000 during Q1 2025.